The 3rd annual meeting of the Global Retinal Network Program, an educational initiative developed by Bayer to foster scientific exchange and dialogue, attracted more than 350 delegates from 31 countries. A faculty of international retina specialists reviewed and debated current knowledge, shared clinical experience and considered practical approaches for achieving and maintaining optimal outcomes in the management of patients with retinal disease. This supplement has been produced on behalf of Bayer and reports the Bayer-funded and organised 3rd Global Retinal Network Program Annual Meeting, May 20–21, 2017, Lisbon, Portugal. Attributed comment and opinion reflect the views of faculty speakers and participants and do not necessarily reflect those of Bayer. Prescribing information can be found on the last page.
